Cannabis Regulatory Update: CBD, The Farm Bill, and The Punt from FDA to Congress
Earlier this year, the U.S. Food and Drug Administration (FDA) concluded that existing regulatory frameworks for food and supplements are not appropriate for cannabidiol” (CBD) and the agency will “work with Congress on a new way forward.” Since this announcement, speculation on how FDA and Congress will work to handle the ever-evolving over $9.1 billion […]
Cannabis Regulatory Update: CBD, The Farm Bill, and The Punt from FDA to Congress Read More »